Jeil Pharma Holdings Inc

KOSE:A002620 Rapporto sulle azioni

Cap. di mercato: ₩136.5b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Jeil Pharma Holdings Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Seung-Soo Han

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO66.0%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?

Mar 25
Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?

These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively

Feb 27
These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively

What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?

Jan 23
What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?

Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment

Dec 28
Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment

Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet

Nov 23
Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet

AMMINISTRATORE DELEGATO

Seung-Soo Han (77 yo)

no data

Mandato

Seung Soo Han serves the Chairman of the Board and Chief Executive Officer of Jeil Pharma Holdings Inc (formerly known as Jeil Pharmaceutical Co., Ltd.)